{
  "variants": [
    {
      "variant": "PINK1 G309D",
      "gene": "PINK1",
      "protein_change": "G309D",
      "variant_string_id": "PINK1 G309D",
      "functional_evidence_aim": "Pathogenic",
      "flowchart_steps": {
        "step_1": {
          "description": "The paper explicitly states that PINK1 mutations cause PARK6 via loss of function, directly linking the variant to mitochondrial dysfunction.",
          "judgment": "Yes"
        },
        "step_2": {
          "description": "Mitochondrial function assays (ΔΨm, morphology, ROS) are directly relevant to the disease mechanism of PARK6.",
          "judgment": "Yes"
        },
        "step_3": {
          "substeps": {
            "3a": {
              "description": "Controls (wild-type PINK1 and PINK1 knockout) are present, but replicates are not explicitly mentioned in the abstract.",
              "judgment": "No"
            },
            "3b": {
              "description": "Mitochondrial function assays are standard in the field and validated for studying PARK6 pathogenesis.",
              "judgment": "Yes"
            }
          },
          "judgment": "Proceed to Step 3b"
        },
        "step_4": {
          "substeps": {
            "4a": {
              "description": "No explicit OddsPath calculation or statistical analysis is reported in the abstract.",
              "judgment": "No"
            },
            "4b": {
              "description": "Only 1 pathogenic control variant (wild-type PINK1) is used, with no additional benign/pathogenic controls.",
              "judgment": "Max PS3_supporting"
            }
          },
          "judgment": "Max PS3_supporting"
        }
      },
      "evidence_strength": "PS3_supporting"
    },
    {
      "variant": "PINK1 E417G",
      "gene": "PINK1",
      "protein_change": "E417G",
      "variant_string_id": "PINK1 E417G",
      "functional_evidence_aim": "Pathogenic",
      "flowchart_steps": {
        "step_1": {
          "description": "The paper explicitly states that PINK1 mutations cause PARK6 via loss of function, directly linking the variant to mitochondrial dysfunction.",
          "judgment": "Yes"
        },
        "step_2": {
          "description": "Mitochondrial function assays (ΔΨm, morphology, ROS) are directly relevant to the disease mechanism of PARK6.",
          "judgment": "Yes"
        },
        "step_3": {
          "substeps": {
            "3a": {
              "description": "Controls (wild-type PINK1 and PINK1 knockout) are present, but replicates are not explicitly mentioned in the abstract.",
              "judgment": "No"
            },
            "3b": {
              "description": "Mitochondrial function assays are standard in the field and validated for studying PARK6 pathogenesis.",
              "judgment": "Yes"
            }
          },
          "judgment": "Proceed to Step 3b"
        },
        "step_4": {
          "substeps": {
            "4a": {
              "description": "No explicit OddsPath calculation or statistical analysis is reported in the abstract.",
              "judgment": "No"
            },
            "4b": {
              "description": "Only 1 pathogenic control variant (wild-type PINK1) is used, with no additional benign/pathogenic controls.",
              "judgment": "Max PS3_supporting"
            }
          },
          "judgment": "Max PS3_supporting"
        }
      },
      "evidence_strength": "PS3_supporting"
    },
    {
      "variant": "PINK1 CΔ145",
      "gene": "PINK1",
      "protein_change": "CΔ145",
      "variant_string_id": "PINK1 CΔ145",
      "functional_evidence_aim": "Pathogenic",
      "flowchart_steps": {
        "step_1": {
          "description": "The paper explicitly states that PINK1 mutations cause PARK6 via loss of function, directly linking the variant to mitochondrial dysfunction.",
          "judgment": "Yes"
        },
        "step_2": {
          "description": "Mitochondrial function assays (ΔΨm, morphology, ROS) are directly relevant to the disease mechanism of PARK6.",
          "judgment": "Yes"
        },
        "step_3": {
          "substeps": {
            "3a": {
              "description": "Controls (wild-type PINK1 and PINK1 knockout) are present, but replicates are not explicitly mentioned in the abstract.",
              "judgment": "No"
            },
            "3b": {
              "description": "Mitochondrial function assays are standard in the field and validated for studying PARK6 pathogenesis.",
              "judgment": "Yes"
            }
          },
          "judgment": "Proceed to Step 3b"
        },
        "step_4": {
          "substeps": {
            "4a": {
              "description": "No explicit OddsPath calculation or statistical analysis is reported in the abstract.",
              "judgment": "No"
            },
            "4b": {
              "description": "Only 1 pathogenic control variant (wild-type PINK1) is used, with no additional benign/pathogenic controls.",
              "judgment": "Max PS3_supporting"
            }
          },
          "judgment": "Max PS3_supporting"
        }
      },
      "evidence_strength": "PS3_supporting"
    }
  ]
}